Corneal Endothelial Cell Changes
1 clinical trials · Condition
◉ Watch Corneal Endothelial Cell Changes
| Record | Firm | Date |
|---|---|---|
| Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 Days (NCT01736462) | Bausch & Lomb Incorporated | 2013-02-01 |
Track Corneal Endothelial Cell Changes automatically
Every clearance here is in the API, with alerts when new ones post.